What Is a DHT Blocker, and How Does It Actually Work?

A DHT blocker is any product or medicine marketed to reduce the effect of dihydrotestosterone (DHT), the hormone most directly responsible for androgenetic alopecia, the medical name for pattern hair loss. That single phrase covers a very wide range of things, from a prescription drug that lowers serum DHT by around 70% in controlled studies to a shampoo whose evidence stops at a laboratory dish. Understanding which tier a given "DHT blocker" actually sits in matters far more than the label, and that tier is what this article sets out to make clear before any product enters the picture. For the fuller mechanism of androgenetic alopecia beyond DHT alone, the dedicated overview article covers that ground in more depth.

• DHT is made from testosterone and binds far more tightly to receptors inside hair follicles, which is why a genetically sensitive follicle responds strongly to it even though DHT itself is a normal, necessary hormone elsewhere in the body.
• Only two drugs, finasteride and dutasteride, have strong, repeatedly measured evidence for suppressing DHT and slowing hair loss; everything else marketed as a "DHT blocker" sits in a much weaker evidence category.
• Saw palmetto and pumpkin seed oil have some human trial data behind them, but the trials are small, short, and mostly run or funded by the company selling the product being tested.
• Minoxidil, the strongest-evidenced product in this range, does not touch DHT at all; it works through a separate mechanism, which is worth understanding so the two approaches aren't confused with each other.

What DHT Actually Is

Testosterone is not, on its own, the hormone that drives most pattern hair loss. Inside hair follicle cells, an enzyme called 5-alpha-reductase, mainly its type II and III forms in the scalp, converts testosterone into dihydrotestosterone. DHT then binds the androgen receptor considerably more strongly than testosterone does, which is why a relatively small amount of it can have an outsized effect on a follicle that happens to carry the genetic sensitivity for pattern hair loss (source: Investigating the Relationship Between Androgenetic Alopecia and DHT).

It helps to be precise about what "the problem" actually is here. DHT is not a rogue hormone that needs eliminating; it plays a normal role elsewhere in the body, including in male development and in other tissues throughout life. What differs in someone with androgenetic alopecia is how their scalp follicles are built to respond to it. Two people can have similar DHT levels and see completely different outcomes, because the sensitivity is inherited at the follicle, not set by the hormone level alone. That distinction is also why this article stays focused on the general, largely male-pattern mechanism; DHT's role in female pattern hair loss follows a related but distinct pattern that a separate article on DHT in women covers on its own terms.

How DHT Drives Pattern Hair Loss

The effect happens inside the dermal papilla, a small cluster of cells at the base of each follicle that effectively runs the hair growth cycle. When DHT binds the androgen receptor there, it disrupts the signalling that keeps a follicle in its growth phase, including a pathway called Wnt/beta-catenin, partly by raising a protein called DKK1 that suppresses it. The practical result is that the anagen (growth) phase gets shorter with each cycle while telogen (the resting phase before a hair sheds) gets longer (source: Investigating the Relationship Between Androgenetic Alopecia and DHT).

Why this is gradual, not sudden

Because the shift happens cycle by cycle rather than all at once, the visible change is miniaturisation: each regrowth produces a slightly finer, shorter hair than the one before it, until some follicles stop producing a hair that reaches the surface at all. That is why pattern hair loss tends to be noticed as gradual thinning over months and years rather than as sudden shedding, and why the timeline for any treatment aimed at this mechanism is also measured in months rather than days.

The Strong Tier: Prescription 5-Alpha-Reductase Inhibitors

Only two medicines have strong, repeatedly measured evidence for reducing the DHT that drives this process, and both work by inhibiting the enzyme itself rather than anything downstream of it. Neither is sold here, and nothing below is dosing or start/stop guidance; a doctor is the right person to weigh the known side effects and decide whether either drug is appropriate for a given person.

Finasteride

Finasteride inhibits type II and III 5-alpha-reductase, with little effect on type I. Oral finasteride at 1 mg received FDA approval in 1997 specifically for androgenetic alopecia in men, and it reduces serum DHT by roughly 70% (source: Finasteride, StatPearls). In people who continue taking it, hair count has been measured recovering partially within about the first 12 months, but the drug is understood to slow the progression of the condition rather than cure it, and the gains depend on continuing treatment (source: Finasteride, StatPearls).

Dutasteride

Dutasteride blocks both the type I and type II forms of the enzyme, which is why it suppresses DHT more completely, roughly 94-95% in clinical studies compared with about 70% for finasteride (source: Comparison of Clinical Trials With Finasteride and Dutasteride). In the United States it is FDA-approved only for an enlarged prostate, so its use for hair loss there is off-label, while South Korea, Japan and Taiwan have specifically approved that use (source: Dutasteride, International Society of Hair Restoration Surgery). For a direct, honest comparison between this tier and the natural extracts covered next, the saw palmetto versus finasteride article puts the two side by side.

The Weak Tier: Saw Palmetto, Pumpkin Seed Oil and Other "Natural" Blockers

A lot of what gets marketed as a natural DHT blocker starts from a real finding and then asks it to carry more weight than it can. The two extracts with the most human data behind them are saw palmetto and pumpkin seed oil, and even their strongest trials come with real limits worth knowing before treating either as comparable to a prescription drug.

Saw palmetto

Saw palmetto's fatty acids and phytosterols have inhibited 5-alpha-reductase in laboratory assays, which is a genuine finding, but it sits a long way from a demonstrated effect on a living scalp. A 16-week randomised, placebo-controlled trial of a standardised saw palmetto oil in 80 participants found that oral use reduced hair fall by about 29% and topical use by about 22%, with modest density gains of around 5% and 8% respectively, while the placebo groups got slightly worse. The trial's own authors, who were affiliated with the company behind the product, flagged its short duration, small size, and the absence of any comparison against a standard AGA medication (source: Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall).

Pumpkin seed oil

A separate 24-week randomised, double-blind, placebo-controlled trial gave oral pumpkin seed oil to 76 men with mild-to-moderate androgenetic alopecia and measured roughly a 40% increase in hair count, against about 10% with placebo. Notably, the researchers never measured DHT or related hormone markers in that trial, so they could not actually explain the mechanism behind their own result, and the study was funded by the company that supplies the oil (source: Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia). Neither of these trials involved a rinse-off shampoo, where the active ingredients have a couple of minutes of scalp contact before the product goes down the drain, which is worth keeping in mind for any wash-in product that borrows the same ingredient names.

Why Minoxidil Isn't a DHT Blocker, and That's Fine

It's easy to lump every hair-loss product into the same "DHT blocker" bucket, but minoxidil doesn't belong there at all. It doesn't act on DHT or on 5-alpha-reductase in any way. Its proposed mechanisms instead include opening ATP-sensitive potassium channels and dilating blood vessels in the scalp, raising VEGF and other growth factors, and directly prolonging the anagen phase while shortening telogen (source: Minoxidil and its use in hair disorders: a review).

That different mechanism is exactly why minoxidil has built its own strong evidence base rather than needing to compete with DHT blockers on the same terms; it is solving a different part of the problem. Someone dealing with DHT-driven miniaturisation can reasonably use a DHT-lowering approach for one reason and a growth-stimulating approach for another, without treating the two as duplicates of each other or expecting one to substitute for the other.

Where a Saw Palmetto Shampoo Actually Fits

Given everything above, it's worth being direct about where a saw palmetto shampoo sits in this picture: in the weak tier, as a wash-step product, not as a stand-in for a strong-tier treatment. A shampoo's active ingredients get a genuinely short window of scalp contact before rinsing, and none of the human trials on saw palmetto have tested that format specifically. That doesn't make the ingredient pointless in a shampoo; it makes the honest framing a scalp-comfort step within a routine rather than a treatment claim.

The Saw Palmetto DHT Shampoo makes the most sense paired with a leave-on product that has real regrowth evidence behind it, for someone who wants their wash step to at least align with that goal rather than work against it, for example by using a milder formula on a scalp that a topical treatment has left dry or irritated.

Where any individual reader lands on this spectrum is a genuinely personal decision, and it starts with a doctor for anything in the prescription tier, since that is the only place where dosing and suitability should be decided. A wash-step product like a saw palmetto shampoo is a reasonable, honestly-scoped companion inside a broader regimen, chosen for what it is rather than mistaken for what it isn't. The rest of the Understanding Hair Loss series covers the surrounding questions, from the androgenetic alopecia mechanism in full to how the range's other actives compare on the same evidence ladder.